Intercept in mixed effects model [Software]

posted by Imph – Algeria, 2022-10-25 11:47 (105 d 10:40 ago) – Posting: # 23349
Views: 1,094


To assess average bioequivalence based on a mixed effect model in Phoenix WinNonlin, do we have to include the intercept term for the fixed effects and the random intercept for the random effects? does the analysis change with the inclusion or non-inclusion of the intercept term.

Best regards.

Complete thread:

UA Flag
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
24 visitors (0 registered, 24 guests [including 11 identified bots]).
Forum time: 21:27 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz